Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03542682 · ClinicalTrials.gov registry record · NA
The Effect of Bolus Speed of Rapid-Acting Insulin Analog Absorption and Action in Individuals With Type 1 Diabetes
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT03542682 is a NA study that has completed, run by Yale University. The registered enrollment target is 11 participants.
The verdict
NCT03542682, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
Rapid Action Insulin (RAI) absorption and action measured by time to reach maximum insulin concentration and glucose infusion rate.
Interventions
- DEVICE Quick Bolus
- DEVICE Standard Bolus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2018-05-30 |
| Est. Completion | 2022-09-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03542682
The ClinicalTrials.gov registry entry for NCT03542682 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Quick Bolus is the first listed.
NCT03542682 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03542682 about?
NCT03542682 is a clinical study titled "The Effect of Bolus Speed of Rapid-Acting Insulin Analog Absorption and Action in Individuals With Type 1 Diabetes". Rapid Action Insulin (RAI) absorption and action measured by time to reach maximum insulin concentration and glucose infusion rate.
What is the current status of trial NCT03542682?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2018-05-30. Estimated completion is 2022-09-23.
What interventions are being tested in trial NCT03542682?
The interventions under investigation include: Quick Bolus (DEVICE), Standard Bolus (DEVICE).
Who is sponsoring clinical trial NCT03542682?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.